The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Superparamagnetic iron oxide: pharmacokinetics and toxicity
Open accessAbstract
The pharmacokinetics (distribution, metabolism, bioavailability, excretion) and toxicity (acute and subacute toxicity, mutagenicity) of a superparamagnetic iron oxide preparation (AMI-25), currently used in clinical trials, were evaluated by 59Fe radiotracer studies, measurements of relaxation times, the ability to reverse iron deficiency anemia, histologic examination, and laboratory parameters. One hour after administration of AMI-25 to rats (18 mumol Fe/kg; 1 mg Fe/kg), 82.6 +/- 0.3% of the administered dose was sequestered in the liver and 6.2 +/- 7.6% in the spleen. Peak concentrations of 59Fe were found in liver after 2 hr and in the spleen after 4 hr. 59Fe slowly cleared from liver (half-life, 3 days) and spleen (half-life, 4 days) and was incorporated into hemoglobin of erythrocytes in a time-dependent fashion. The half-time of the T2 effect on liver and spleen (24-48 hr) was shorter than the 59Fe clearance, indicating metabolism of AMI-25 into other forms of iron. IV administration of AMI-25 (30 mg Fe/kg) corrected iron-deficiency anemia and showed bioavailability similar to that of commercially available IV iron preparations within 7 days. No acute or subacute toxic effects were detected by histologic or serologic studies in rats or beagle dogs who received a total of 3000 mumol Fe/kg, 150 times the dose proposed for MR imaging of the liver. Our results indicate that AMI-25 is a fully biocompatible potential contrast agent for MR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Carleton's Histological technique
Carleton, H. M., Drury, R. A. B., & Wallington, E. A. (1967) · Oxford University Press eBooks · Cited by 1,038
Identifying Environmental Chemicals Causing Mutations and Cancer
Ames, B. N. (1979) · Science · doi:10.1126/science.373122 · Cited by 586
Ferromagnetic particles as contrast agents for magnetic resonance imaging of liver and spleen
Dias, M. H. M., & Lauterbur, P. C. (1986) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910030218 · Cited by 180
Ferromagnetic contrast agents: A new approach
Renshaw, P. F., Owen, C. S., McLaughlin, A. C., Frey, T. G., & Leigh, J. S. (1986) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910030205 · Cited by 162
Hershko, C., Cook, J. D., & Da, F. (1973) · PubMed · Cited by 114
A functionalized superparamagnetic iron oxide colloid as a receptor directed MR contrast agent
Josephson, L., Groman, E., Menz, E. T., Lewis, J. M., & Bengele, H. H. (1990) · Magnetic Resonance Imaging · doi:10.1016/0730-725x(90)90143-p · Cited by 88
Self-citationThe diagnosis of splenic lymphoma by MR imaging: value of superparamagnetic iron oxide
Weissleder, R., Elizondo, G., Stark, D. D., Hahn, P. F., Marfil, J., Gonzalez, J., Saini, S., Todd, L., & Ferrucci, J. T. (1989) · American Journal of Roentgenology · doi:10.2214/ajr.152.1.175 · Cited by 86
Self-citationPouliquen, D., Perdrisot, R., Ermias, A., et al. (1989) · Magnetic Resonance Imaging · doi:10.1016/0730-725x(89)90530-4 · Cited by 71
Rozenman, Y., Zou, X., & Kantor, H. L. (1990) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910140105 · Cited by 37
Cited by
Reddy, L. H., Arias, J. L., Nicolas, J., & Couvreur, P. (2012) · Chemical Reviews · doi:10.1021/cr300068p · Cited by 2,010
Magnetic nanoparticle design for medical diagnosis and therapy
Mornet, S., Vasseur, S., Grasset, F., & Duguet, E. (2004) · Journal of Materials Chemistry · doi:10.1039/b402025a · Cited by 1,745
Sharifi, S., Behzadi, S., Laurent, S., Laird Forrest, M., Stroeve, P., & Mahmoudi, M. (2012) · Chem. Soc. Rev. · doi:10.1039/c1cs15188f · Cited by 1,460
Wang, Y.-X. J., Hussain, S. M., & Krestin, G. P. (2001) · European Radiology · doi:10.1007/s003300100908 · Cited by 1,381
Biological applications of magnetic nanoparticles
Colombo, M., Carregal-Romero, S., Casula, M. F., Gutiérrez, L., Morales, M. P., Böhm, I. B., Heverhagen, J. T., Prosperi, D., & Parak, W. J. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15337h · Cited by 1,315
Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers
Wahajuddin, & Arora (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s30320 · Cited by 1,117
Multifunctional magnetic nanoparticles for targeted imaging and therapy
MCCARTHY, J., & WEISSLEDER, R. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.03.014 · Cited by 892
Self-citationde Vries, I. J. M., Lesterhuis, W. J., Barentsz, J. O., Verdijk, P., van Krieken, J. H., Boerman, O. C., Oyen, W. J. G., Bonenkamp, J. J., Boezeman, J. B., Adema, G. J., et al. (2005) · Nature Biotechnology · doi:10.1038/nbt1154 · Cited by 821
Biomedical Nanomagnetics: A Spin Through Possibilities in Imaging, Diagnostics, and Therapy
Krishnan, K. M. (2010) · IEEE Transactions on Magnetics · doi:10.1109/tmag.2010.2046907 · Cited by 819
Imaging macrophages with nanoparticles
Weissleder, R., Nahrendorf, M., & Pittet, M. J. (2014) · Nature Materials · doi:10.1038/nmat3780 · Cited by 809
Superparamagnetic Iron Oxide Nanoparticle Probes for Molecular Imaging
Thorek, D. L. J., Chen, A. K., Czupryna, J., & Tsourkas, A. (2006) · Annals of Biomedical Engineering · doi:10.1007/s10439-005-9002-7 · Cited by 772
Superparamagnetic iron oxide nanoparticles: from preparations to in vivo MRI applications
Qiao, R., Yang, C., & Gao, M. (2009) · Journal of Materials Chemistry · doi:10.1039/b902394a · Cited by 685
Tassa, C., Shaw, S. Y., & Weissleder, R. (2011) · Accounts of Chemical Research · doi:10.1021/ar200084x · Cited by 653
Self-citationVillaraza, A. J. L., Bumb, A., & Brechbiel, M. W. (2010) · Chemical Reviews · doi:10.1021/cr900232t · Cited by 632
Reimer, P., & Balzer, T. (2003) · European Radiology · doi:10.1007/s00330-002-1721-7 · Cited by 614
Yu, M. K., Jeong, Y. Y., Park, J., Park, S., Kim, J. W., Min, J. J., Kim, K., & Jon, S. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200800857 · Cited by 615
Kunzmann, A., Andersson, B., Thurnherr, T., Krug, H., Scheynius, A., & Fadeel, B. (2011) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2010.04.007 · Cited by 527
Electromagnetic activation of shape memory polymer networks containing magnetic nanoparticles
Schmidt, A. M. (2006) · Macromolecular Rapid Communications · doi:10.1002/marc.200600225 · Cited by 518
A Review of Clinical Translation of Inorganic Nanoparticles
Anselmo, A. C., & Mitragotri, S. (2015) · The AAPS Journal · doi:10.1208/s12248-015-9780-2 · Cited by 509
Nanoparticles in modern medicine: state of the art and future challenges.
(2007) · PubMed Central · Cited by 484
Tay, Z. W., Chandrasekharan, P., Chiu-Lam, A., Hensley, D. W., Dhavalikar, R., Zhou, X. Y., Yu, E. Y., Goodwill, P. W., Zheng, B., Rinaldi, C., et al. (2018) · ACS Nano · doi:10.1021/acsnano.8b00893 · Cited by 459
In vivo MRI cell tracking: clinical studies
Bulte, J. W. M. (2009) · American Journal of Roentgenology · doi:10.2214/ajr.09.3107 · Cited by 430
In vivo degeneration and the fate of inorganic nanoparticles
Feliu, N., Docter, D., Heine, M., del Pino, P., Ashraf, S., Kolosnjaj-Tabi, J., Macchiarini, P., Nielsen, P., Alloyeau, D., Gazeau, F., et al. (2016) · Chemical Society Reviews · doi:10.1039/c5cs00699f · Cited by 423
Nanotechnology, nanotoxicology, and neuroscience
Suh, W. H., Suslick, K. S., Stucky, G. D., & Suh, Y.-H. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.09.009 · Cited by 406
Long-circulating iron oxides for MR imaging
Weissleder, R., Bogdanov, A., Neuwelt, E. A., & Papisov, M. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00033-4 · Cited by 398
Self-citationSynthesis of phase-pure and monodisperse iron oxide nanoparticles by thermal decomposition
Hufschmid, R., Arami, H., Ferguson, R. M., Gonzales, M., Teeman, E., Brush, L. N., Browning, N. D., & Krishnan, K. M. (2015) · Nanoscale · doi:10.1039/c5nr01651g · Cited by 341
Norouzi, M., Yathindranath, V., Thliveris, J. A., Kopec, B. M., Siahaan, T. J., & Miller, D. W. (2020) · Scientific Reports · doi:10.1038/s41598-020-68017-y · Cited by 292
In Vivo Magnetic Resonance Tracking of Magnetically Labeled Cells after Transplantation
Bulte, J. W. M., Duncan, I. D., & Frank, J. A. (2002) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200208000-00001 · Cited by 288
Sizing it up: Cellular MRI using micron‐sized iron oxide particles
Shapiro, E. M., Skrtic, S., & Koretsky, A. P. (2005) · Magnetic Resonance in Medicine · doi:10.1002/mrm.20342 · Cited by 288
Cell Uptake and in Vitro Toxicity of Magnetic Nanoparticles Suitable for Drug Delivery
Häfeli, U. O., Riffle, J. S., Harris-Shekhawat, L., Carmichael-Baranauskas, A., Mark, F., Dailey, J. P., & Bardenstein, D. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900083m · Cited by 277
Biodegradation of Iron Oxide Nanocubes: High-Resolution In Situ Monitoring
Lartigue, L., Alloyeau, D., Kolosnjaj-Tabi, J., Javed, Y., Guardia, P., Riedinger, A., Péchoux, C., Pellegrino, T., Wilhelm, C., & Gazeau, F. (2013) · ACS Nano · doi:10.1021/nn305719y · Cited by 274
Generation of magnetic nonviral gene transfer agents and magnetofection in vitro
Mykhaylyk, O., Antequera, Y. S., Vlaskou, D., & Plank, C. (2007) · Nature Protocols · doi:10.1038/nprot.2007.352 · Cited by 272
Zhu, L., Zhou, Z., Mao, H., & Yang, L. (2017) · Nanomedicine · doi:10.2217/nnm-2016-0316 · Cited by 267
Use of magnetic fields and nanoparticles to trigger drug release and improve tumor targeting
Liu, J. F., Jang, B., Issadore, D., & Tsourkas, A. (2019) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1571 · Cited by 265
Polyak, B., Fishbein, I., Chorny, M., Alferiev, I., Williams, D., Yellen, B., Friedman, G., & Levy, R. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708338105 · Cited by 257
Perturbational profiling of nanomaterial biologic activity
Shaw, S. Y., Westly, E. C., Pittet, M. J., Subramanian, A., Schreiber, S. L., & Weissleder, R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802878105 · Cited by 248
Self-citationHamm, B., Staks, T., Taupitz, M., Maibauer, R., Speidel, A., Huppertz, A., Frenzel, T., Lawaczeck, R., Wolf, K. J., & Lange, L. (1994) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.1880040508 · Cited by 187
Pablico-Lansigan, M. H., Situ, S. F., & Samia, A. C. S. (2013) · Nanoscale · doi:10.1039/c3nr00544e · Cited by 172
Morishige, K., Kacher, D. F., Libby, P., Josephson, L., Ganz, P., Weissleder, R., & Aikawa, M. (2010) · Circulation · doi:10.1161/circulationaha.109.891804 · Cited by 168
Self-citationMagnetic Nanostructures: Rational Design and Fabrication Strategies toward Diverse Applications
Wang, S., Xu, J., Li, W., Sun, S., Gao, S., & Hou, Y. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00370 · Cited by 129
Bernd, H., De Kerviler, E., Gaillard, S., & Bonnemain, B. (2009) · Investigative Radiology · doi:10.1097/rli.0b013e3181a0068b · Cited by 115
Kim, J. I., Chun, C., Kim, B., Hong, J. M., Cho, J.-K., Lee, S. H., & Song, S.-C. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2011.09.033 · Cited by 108
Upponi, J. R., Jerajani, K., Nagesha, D. K., Kulkarni, P., Sridhar, S., Ferris, C., & Torchilin, V. P. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.03.054 · Cited by 105
Organ-specific toxicity of magnetic iron oxide-based nanoparticles
Chrishtop, V. V., Mironov, V. A., Prilepskii, A. Y., Nikonorova, V. G., & Vinogradov, V. V. (2021) · Nanotoxicology · doi:10.1080/17435390.2020.1842934 · Cited by 86
Design of superparamagnetic nanoparticles for magnetic particle imaging (MPI)
Du, Y., Lai, P., Leung, C., & Pong, P. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140918682 · Cited by 81
Prediction of anti-cancer nanotherapy efficacy by imaging
Miller, M. A., Arlauckas, S., & Weissleder, R. (2017) · Nanotheranostics · doi:10.7150/ntno.20564 · Cited by 74
Self-citationMonocyte Subset Dynamics in Human Atherosclerosis Can Be Profiled with Magnetic Nano-Sensors
Wildgruber, M., Lee, H., Chudnovskiy, A., Yoon, T.-J., Etzrodt, M., Pittet, M. J., Nahrendorf, M., Croce, K., Libby, P., Weissleder, R., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005663 · Cited by 54
Self-citationGadoxetate acid-enhanced MR imaging for HCC: A review for clinicians
Chanyaputhipong, J., Low, S.-C. A., & Chow, P. K. H. (2011) · International Journal of Hepatology · doi:10.4061/2011/489342 · Cited by 41
Bio‐based hyperbranched polyurethane/Fe3O4 nanocomposites as shape memory materials
Kalita, H., & Karak, N. (2013) · Polymers for Advanced Technologies · doi:10.1002/pat.3149 · Cited by 30
Toxicity of Magnetic Nanoparticles in Medicine: Contributing Factors and Modern Assessment Methods
Nowak-Jary, J., & Machnicka, B. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178586 · Cited by 25
Metadata
- Authors
- Weissleder, R., Stark, D., Engelstad, B., Bacon, B., Compton, C., White, D., Jacobs, P., & Lewis, J.
- Venue
- American Journal of Roentgenology
- Publisher
- American Roentgen Ray Society
- Published
- 1989-01-01
- Volume
- 152
- Issue
- 1
- Pages
- 167-173
- ISSN
- 0002-9580 (ISSN-L)
- 0361-803X
- 1546-3141
- OpenAlex
- W2154620120
- Cited by
- 1,045
- References
- 9
- FWCI
- 4.39
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.